Literature DB >> 3905476

The relationship of cardiovascular risk factors to the prevalence of coronary heart disease in newly diagnosed type 2 (non-insulin-dependent) diabetes.

M Uusitupa, O Siitonen, K Pyörälä, A Aro, K Hersio, I Penttilä, E Voutilainen.   

Abstract

The relationship of cardiovascular risk factors to the prevalence of coronary heart disease was examined in 133 newly diagnosed Type 2 (non-insulin-dependent) diabetic patients (70 men, 63 women) aged from 45 to 64 years and in 144 randomly selected non-diabetic control subjects (62 men, 82 women) of the same age. The prevalence of coronary heart disease in diabetic patients, defined by symptoms and ischaemic ECG abnormalities in resting or exercise ECG, was more than threefold that in non-diabetic subjects. In multiple logistic analyses (including age, history of smoking, hypertension (+/-), serum cholesterol, HDL-cholesterol, triglycerides, 2-h post-glucose serum insulin, body mass index and diabetes (+/-] carried out separately for men and women, diabetes showed an independent, significant association to coronary heart disease in both sexes. In addition, age and hypertension had a borderline association to coronary heart disease in men, whereas smoking and high 2-h post-glucose serum insulin level showed a significant association in women.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3905476     DOI: 10.1007/bf00291970

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  24 in total

1.  Excessive serum insulin response to oral glucose in obesity and mild diabetes. Study of 501 patients.

Authors:  R Chiles; M Tzagournis
Journal:  Diabetes       Date:  1970-06       Impact factor: 9.461

2.  Atherosclerosis in diabetes mellitus. Correlations with serum lipid levels, adiposity, and serum insulin level.

Authors:  R J Santen; P W Willis; S S Fajans
Journal:  Arch Intern Med       Date:  1972-12

3.  Worsening to diabetes in men with impaired glucose tolerance ("borderline diabetes").

Authors:  R J Jarrett; H Keen; J H Fuller; M McCartney
Journal:  Diabetologia       Date:  1979-01       Impact factor: 10.122

4.  The Bedford survey: ten year mortality rates in newly diagnosed diabetics, borderline diabetics and normoglycaemic controls and risk indices for coronary heart disease in borderline diabetics.

Authors:  R J Jarrett; P McCartney; H Keen
Journal:  Diabetologia       Date:  1982-02       Impact factor: 10.122

5.  The ten-year follow-up of the Bedford survey (1962-1972): glucose tolerance and diabetes.

Authors:  H Keen; R J Jarrett; P McCartney
Journal:  Diabetologia       Date:  1982-02       Impact factor: 10.122

6.  Diabetes and cardiovascular risk factors: the Framingham study.

Authors:  W B Kannel; D L McGee
Journal:  Circulation       Date:  1979-01       Impact factor: 29.690

7.  Comparison of different analytical and precipitation methods for direct estimation of serum high-density lipoprotein cholesterol.

Authors:  I M Penttilä; E Voutilainen; P Laitinen; P Juutilainen
Journal:  Scand J Clin Lab Invest       Date:  1981-06       Impact factor: 1.713

8.  Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations.

Authors:  T A Welborn; K Wearne
Journal:  Diabetes Care       Date:  1979 Mar-Apr       Impact factor: 19.112

9.  Coronary-heart-disease risk and impaired glucose tolerance. The Whitehall study.

Authors:  J H Fuller; M J Shipley; G Rose; R J Jarrett; H Keen
Journal:  Lancet       Date:  1980-06-28       Impact factor: 79.321

10.  Hyperinsulinaemia is associated with development of electrocardiographic abnormalities in diabetics.

Authors:  R M Hillson; T D Hockaday; J I Mann; D J Newton
Journal:  Diabetes Res       Date:  1984-09
View more
  11 in total

Review 1.  Hypertension in non-insulin dependent diabetes mellitus and its management.

Authors:  M D Feher
Journal:  Postgrad Med J       Date:  1991-10       Impact factor: 2.401

2.  Interaction of non-esterified fatty acid and insulin in control of triacylglycerol secretion by Hep G2 cells.

Authors:  C D Byrne; N P Brindle; T W Wang; C N Hales
Journal:  Biochem J       Date:  1991-11-15       Impact factor: 3.857

Review 3.  Mortality and survival in type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  G Panzram
Journal:  Diabetologia       Date:  1987-03       Impact factor: 10.122

Review 4.  Triglycerides and disease.

Authors:  C A Seymour; C D Byrne
Journal:  Postgrad Med J       Date:  1993-09       Impact factor: 2.401

5.  Incidence, prevalence and coronary heart disease risk level in known Type 2 diabetes: a sentinel practice network study in the Basque Country, Spain.

Authors:  J M Arteagoitia; M I Larrañaga; J L Rodriguez; I Fernandez; J A Piniés
Journal:  Diabetologia       Date:  2003-06-27       Impact factor: 10.122

6.  Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and non-diabetic subjects.

Authors:  M I Uusitupa; L K Niskanen; O Siitonen; E Voutilainen; K Pyörälä
Journal:  Diabetologia       Date:  1993-11       Impact factor: 10.122

7.  Control of Hep G2-cell triacylglycerol and apolipoprotein B synthesis and secretion by polyunsaturated non-esterified fatty acids and insulin.

Authors:  C D Byrne; T W Wang; C N Hales
Journal:  Biochem J       Date:  1992-11-15       Impact factor: 3.857

Review 8.  Adverse cardiovascular effects of sulphonylurea drugs. Clinical significance.

Authors:  R Huupponen
Journal:  Med Toxicol       Date:  1987 May-Jun

9.  Cardiovascular risk factors and prevalence of coronary heart disease in type 2 (non-insulin-dependent) diabetes.

Authors:  H Vlajinac; M Ilic; J Marinkovic
Journal:  Eur J Epidemiol       Date:  1992-11       Impact factor: 8.082

Review 10.  Can Cardiovascular Epidemiology and Clinical Trials Close the Risk Management Gap Between Diabetes and Prediabetes?

Authors:  Leigh Perreault; Kristine Færch; Edward W Gregg
Journal:  Curr Diab Rep       Date:  2017-09       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.